NeuroPace, Inc. Profile Avatar - Palmy Investing

NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the …

Medical - Devices
US, Mountain View [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

NeuroPace, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of NPCE's Analysis
CIK: 1528287 CUSIP: 641288105 ISIN: US6412881053 LEI: - UEI: -
Secondary Listings
NPCE has no secondary listings inside our databases.